Hydralazine Hydrochloride Tablet
Product Images NDC 63629-8494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 63629-8494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Image 01)

Chem Structure (Image 01)
Chemical structure of hydralazine hydrochloride, showing the molecular arrangement of its atoms in a bicyclic framework with attached hydrazine and hydrochloride groups.*
FDA Label Image

Label (Lbl636298494)

Label (Lbl636298494)
Hydralazine Hydrochloride Tablets USP, 10 mg, oral tablet packaging label showing the labeler Bryant Ranch Prepack and manufacturer Sciegen Pharmaceuticals, Inc. The label includes storage instructions, child-resistant closure information, and a total count of 100 tablets. The NDC number 63629-8494-1 and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.